Akari Therapeutics (AKTX) Shares Issued (2012 - 2025)

Akari Therapeutics' Shares Issued history runs 10 years deep, the most recent figure standing at $1.0 million for Q4 2025.

• In Q4 2025, Shares Issued rose 3803.7% year-over-year to $1.0 million; the TTM figure through Dec 2025 stood at $6.9 million (up 343850.0% YoY), while the FY2025 annual figure was $10.7 million, up 536150.0% from the prior year.
• Shares Issued came in at $1.0 million for Q4 2025 at Akari Therapeutics, down from $4.8 million in the prior quarter.
• In the past five years, Shares Issued ranged from a high of $13176.3 billion in Q3 2021 to a low of -$1.7 million in Q2 2024.
• A 5-year average of $1013.6 billion and a median of $1.7 million in 2023 frame the typical range for Shares Issued.
• Across the five-year window, Shares Issued sank 101.5% in 2024 and surged 3803.7% in 2025, its largest moves.
• Akari Therapeutics' Shares Issued stood at $5.4 million in 2021, then jumped by 129.01% to $12.4 million in 2022, then tumbled by 85.44% to $1.8 million in 2023, then slumped by 101.5% to -$27000.0 in 2024, then soared by 3803.7% to $1.0 million in 2025.
• According to Business Quant data, Shares Issued over the past three periods registered $1.0 million, $4.8 million, and $1.1 million for Q4 2025, Q2 2025, and Q1 2025 respectively.

Peer Comparison